Predicting response to cognitive-behavioral therapy in a sample of HIV-positive patients with chronic pain

Predictive model of response to therapy

Predictive model of response to therapy with interferon in patients with chronic hepatitis B virus infection: A methodological note

✍ Gioacchino Leandro; M. G. Brook; P. Karayiannis; H. C. Thomas 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 2 views

Prediction of initial cytogenetic respon

Prediction of initial cytogenetic response for subsequent major and complete cytogenetic response to imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia

✍ Mark W. Drummond; Tessa L. Holyoake 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

Prediction of initial cytogenetic respon

Prediction of initial cytogenetic response for subsequent major and complete cytogenetic response to imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia

✍ Hagop Kantarjian; Moshe Talpaz; Susan O'Brien; Francis Giles; Mary Beth Rios; Ke 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

## Abstract ## BACKGROUND Obtaining a major (Philadelphia chromosome [Ph] of < 35%) or a complete cytogenetic response (Ph of 0%) has been associated with excellent long‐term survival. Cytogenetic response may continue to improve with therapy. Because early allogeneic stem cell transplantation (SC

Age as a predicting factor in the therap

Age as a predicting factor in the therapy outcome of multidisciplinary treatment of patients with chronic low back pain—a prospective longitudinal clinical study in 405 patients

✍ Matthias Buchner; Eva Neubauer; Anita Zahlten-Hinguranage; Marcus Schiltenwolf 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 144 KB

Prediction of the response to peg-interf

Prediction of the response to peg-interferon-alfa in patients with HBeAg positive chronic hepatitis B using decline of HBV DNA during treatment

✍ Bettina E. Hansen; Erik H.C.J. Buster; Ewout W. Steyerberg; Emmanuel Lesaffre; H 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

## Abstract Peginterferon (PEG‐IFN) results in HBeAg loss combined with virologic response in only a minority of patients with HBeAg positive chronic hepatitis B. Baseline predictors of response to PEG‐IFN include HBV‐genotype, pre‐treatment HBV DNA levels, and ALT. The aims of this study were to d

Pretreatment prediction of virological r

Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in patients with chronic hepatitis C, using viral and host factors: Some concerns

✍ Chia-Yen Dai; Wan-Long Chuang; Jee-Fu Huang; Ming-Yen Hsieh; Ming-Lung Yu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB 👁 2 views

We read with great interest the article published in a recent issue of HEPATOLOGY. 1 Shirakawa et al. enrolled 120 patients with chronic hepatitis C (CHC) infected with genotype 1 hepatitis C virus (HCV-1) and high baseline viral loads (HVL), defined by HCV RNA levels Ն 10 5 international units (IU)